Independent · Beginner-Friendly · Data-Driven
9 articles found
How 20-year drug patents create billion-dollar moats, why Indian generics companies broke that system, and what patent cliffs mean for investors.
The 12 metrics every investor must check before buying a pharma stock, explained simply with Indian examples from Sun Pharma, Cipla, and Dr. Reddy's.
A deep dive into Mankind Pharma's business: how a Delhi-based company cracked Tier 2/3 India, built the Manforce and Gas-O-Fast brands, and what its premium valuation means for investors.
A beginner's guide to India's pharma value chain: from drug discovery to patient, every stakeholder, business, and investment opportunity explained.
A deep dive into Cipla's business: the 1935 founding, the HIV drug story that changed global pharma, its respiratory franchise, and honest bull and bear cases.
A deep dive into Dr. Reddy's business: how India's most export-focused pharma company built its US generics empire, its Russia franchise, and what the biosimilar bet means.
TCS stock analysis: IT services empire, competitive moats, AI transformation, and investment thesis - beginner guide to Indian tech stocks.
Deep dive into ITC's transformation from tobacco giant to diversified conglomerate - a beginner's guide to understanding multi-business models.
Deep dive into HDFC Bank's history, products, competitive moat, and current business - a beginner's guide to understanding Indian banking.
